A Albenza, Eskazole, Zentel, Andazol, Albendazole CEP of the European Pharmacopoeia monograph is often referred to as a Albenza, Eskazole, Zentel, Andazol, Albendazole Certificate of Suitability (COS). The purpose of a Albenza, Eskazole, Zentel, Andazol, Albendazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Albenza, Eskazole, Zentel, Andazol, Albendazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Albenza, Eskazole, Zentel, Andazol, Albendazole to their clients by showing that a Albenza, Eskazole, Zentel, Andazol, Albendazole CEP has been issued for it. The manufacturer submits a Albenza, Eskazole, Zentel, Andazol, Albendazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Albenza, Eskazole, Zentel, Andazol, Albendazole CEP holder for the record. Additionally, the data presented in the Albenza, Eskazole, Zentel, Andazol, Albendazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Albenza, Eskazole, Zentel, Andazol, Albendazole DMF.
A Albenza, Eskazole, Zentel, Andazol, Albendazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Albenza, Eskazole, Zentel, Andazol, Albendazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Albenza, Eskazole, Zentel, Andazol, Albendazole suppliers with CEP (COS) on PharmaCompass.